Return On Assets in % of ELITE PHARMACEUTICALS INC /NV/ from Q4 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly/annual Return On Assets history and change rate from Q4 2011 to Q3 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Return On Assets for the quarter ending 30 Sep 2025 was 13 %.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Assets for 2024 was -6 %, a 115% decline from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Assets for 2023 was 41 %, a 275% increase from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Assets for 2022 was 11 %, a 65.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 13 +21 01 Jul 2025 30 Sep 2025
Q2 2025 -11 -36 -1.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -4 -34 -1.2% 01 Jan 2025 31 Mar 2025
Q4 2024 -20 -47 -1.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -7 -41 -1.2% 01 Jul 2024 30 Sep 2024
Q2 2024 24 +15 +1.7% 01 Apr 2024 30 Jun 2024
Q1 2024 29 +22 +2.9% 01 Jan 2024 31 Mar 2024
Q4 2023 26 +11 +72.4% 01 Oct 2023 31 Dec 2023
Q3 2023 33 +18 +1.1% 01 Jul 2023 30 Sep 2023
Q2 2023 9 -9 -50.6% 01 Apr 2023 30 Jun 2023
Q1 2023 7 -20 -73.4% 01 Jan 2023 31 Mar 2023
Q4 2022 15 -5 -23.2% 01 Oct 2022 31 Dec 2022
Q3 2022 15 -4 -20.3% 01 Jul 2022 30 Sep 2022
Q2 2022 18 -4 -17.9% 01 Apr 2022 30 Jun 2022
Q1 2022 27 +9 +51% 01 Jan 2022 31 Mar 2022
Q4 2021 20 -4 -15.5% 01 Oct 2021 31 Dec 2021
Q3 2021 19 +10 +96.3% 01 Jul 2021 30 Sep 2021
Q2 2021 22 +29 01 Apr 2021 30 Jun 2021
Q1 2021 18 +28 01 Jan 2021 31 Mar 2021
Q4 2020 23 +48 01 Oct 2020 31 Dec 2020
Q3 2020 10 +36 01 Jul 2020 30 Sep 2020
Q2 2020 -5 +23 +79.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -9 +26 +73.4% 01 Jan 2020 31 Mar 2020
Q4 2019 -24 +9 +27.4% 01 Oct 2019 31 Dec 2019
Q3 2019 -25 -0 -0.35% 01 Jul 2019 30 Sep 2019
Q2 2019 -28 -18 -1.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -34 -23 -2.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -33 -21 -1.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -25 -20 -3.7% 01 Jul 2018 30 Sep 2018
Q2 2018 -10 -12 -7.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -11 -22 -2% 01 Jan 2018 31 Mar 2018
Q4 2017 -12 -58 -1.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -5 -11 -2.1% 01 Jul 2017 30 Sep 2017
Q2 2017 1 +16 01 Apr 2017 30 Jun 2017
Q1 2017 11 +13 01 Jan 2017 31 Mar 2017
Q4 2016 45 +101 01 Oct 2016 31 Dec 2016
Q3 2016 5 -10 -66.1% 01 Jul 2016 30 Sep 2016
Q2 2016 -14 -60 -1.3% 01 Apr 2016 30 Jun 2016
Q1 2016 -2 -23 -1.1% 01 Jan 2016 31 Mar 2016
Q4 2015 -55 +252 +81.9% 01 Oct 2015 31 Dec 2015
Q3 2015 14 +385 01 Jul 2015 30 Sep 2015
Q2 2015 45 +520 01 Apr 2015 30 Jun 2015
Q1 2015 20 +570 01 Jan 2015 31 Mar 2015
Q4 2014 -307 -250 -4.4% 01 Oct 2014 31 Dec 2014
Q3 2014 -370 -388 -21.3% 01 Jul 2014 30 Sep 2014
Q2 2014 -474 -598 -4.8% 01 Apr 2014 30 Jun 2014
Q1 2014 -548 -563 -39.5% 01 Jan 2014 31 Mar 2014
Q4 2013 -57 +12 +17.7% 01 Oct 2013 31 Dec 2013
Q3 2013 18 +94 01 Jul 2013 30 Sep 2013
Q2 2013 123 +74 +1.5% 01 Apr 2013 30 Jun 2013
Q1 2013 14 +154 01 Jan 2013 31 Mar 2013
Q4 2012 -69 +152 +68.7% 01 Oct 2012 31 Dec 2012
Q3 2012 -75 01 Jul 2012 30 Sep 2012
Q2 2012 49 01 Apr 2012 30 Jun 2012
Q1 2012 -140 01 Jan 2012 31 Mar 2012
Q4 2011 -221 01 Oct 2011 31 Dec 2011

ELITE PHARMACEUTICALS INC /NV/ Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -6 -48 -1.1% 01 Apr 2024 31 Mar 2025
2023 41 +31 +2.8% 01 Apr 2023 31 Mar 2024
2022 11 -21 -65.4% 01 Apr 2022 31 Mar 2023
2021 32 +11 +53.6% 01 Apr 2021 31 Mar 2022
2020 21 +29 01 Apr 2020 31 Mar 2021
2019 -8 +20 +70.8% 01 Apr 2019 31 Mar 2020
2018 -28 -18 -1.7% 01 Apr 2018 31 Mar 2019
2017 -10 -24 -1.8% 01 Apr 2017 31 Mar 2018
2016 12 +16 01 Apr 2016 31 Mar 2017
2015 -2 -32 -1.1% 01 Apr 2015 31 Mar 2016
2014 29 +425 01 Apr 2014 31 Mar 2015
2013 -395 -409 -29.5% 01 Apr 2013 31 Mar 2014
2012 13 01 Apr 2012 31 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.